Stefan Ogrodzinski BSc (Hons)

MBA

Director / CEO, OncoTherics Poland sp. z o.o.

Stefan Ogrodzinski received his BSc (Hons) in Toxicology and Pharmacology from The School of Pharmacy, University College London, in 1987 and his MBA from De Montfort University in 1999.

Stefan's career has spanned the pharmaceutical industry, the healthcare sector, the voluntary sector and the educational sector, giving 30 years of sales, marketing, management and directorship experience.

In 2000, Stefan founded BioStatus Ltd and since that time has led the company as its CEO. OncoTherics Ltd was spun out of BioStatus in 2012. As a founding Director of OncoTherics, Stefan is responsible for the early stage fundraising, direction and strategic management of the business. He is also the President of the newly formed, wholly owned Polish subsidiary company, OncoTherics Poland sp. z o.o.

Stefan has also been centrally involved in the development of a number of successful life science companies in the UK, including MedilinkEM Ltd, BioCity Group Ltd, MediCity Ltd and Mobius Technology Ventures Ltd (BioCity's Life Sciences Investment Fund). He is currently an active Director of two early-stage pharmaceutical companies; BioSuspensions Ltd and BioTherics Ltd and sits on the advisory panels for the Centre for Advanced Therapeutics and Nanomedicine and the Centre for Transformative Pharmaceutical Technologies at Nottingham University.